Active — Not RecruitingNot Applicable

Transgender and Gender Diverse Individuals Screening for Breast Cancer

Italy1,600 participantsStarted 2024-05-01

Plain-language summary

The goal of this multicentric prospective study is to evaluate the incidence of Breast Cancer in transgender and gender-diverse population.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Transgender and gender-diverse individuals ≥18 years old who meet the ACR inclusion criteria * Signed Informed Consent Exclusion Criteria: * Refuse to sign Informed Consent

What they're measuring

Incidence of Breast Cancer

Timeframe: 1 year

Trial details

NCT IDNCT06347393

SponsorFondazione Policlinico Universitario Agostino Gemelli IRCCS

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-03-31

View on ClinicalTrials.gov More Breast Cancer trials